Skip to content
Max Marchione@maxmarchione · Nov 16, 2026

This is fascinating. We have an injection in Phase 3 that kills fat cells right where it goes in. It's called CBL-514,…

2 tweets1 min read♥ 2.5Koriginal

Summary

CBL-514, a new injection in Phase 3 trials, destroys fat cells through apoptosis rather than just shrinking them, showing 69.6% of participants losing at least 150 mL of belly fat 8 weeks after treatment compared to none on placebo. Unlike GLP-1s and dieting which reduce fat cell size, this approach permanently reduces fat cell count, potentially offering a less invasive alternative to liposuction.

Summarized by ThreadOut AI from the full thread. May miss nuance — read the thread below.

  1. #1

    This is fascinating. We have an injection in Phase 3 that kills fat cells right where it goes in. It's called CBL-514, and it makes fat cells self-destruct (apoptosis) instead of just shrinking them. This is interesting because your fat cell number is roughly the same throughout your entire life in both lean and obese people. You can diet and be on GLP-1s to make these cells smaller, but they stay. In the Phase 2 trial, 69.6% of people lost at least 150 mL of belly fat 8 weeks after the last treatment (compared with none on placebo). It's not approved yet, and 320 people are currently going through a Phase 3 trial. Frankly, I think a lot of people who’d never consider liposuction would consider this drug.

    Peptime@ItsPeptime · Nov 15, 2026

    BREAKING: New fat loss drug CBL-514 can effectively SPOT REDUCE fat cells! This is going to be a game changer!

  2. #2